Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 5 12 2018
medline: 28 7 2020
entrez: 5 12 2018
Statut: ppublish

Résumé

While previous studies have identified relationships between hippocampal volumes and memory performance in schizophrenia, these relationships are not apparent in healthy individuals. Further, few studies have examined the role of hippocampal subfields in illness-related memory deficits, and no study has examined potential differences across varying illness stages. The current study aimed to investigate whether individuals with early and established psychosis exhibited differential relationships between visuospatial associative memory and hippocampal subfield volumes. Measurements of visuospatial associative memory performance and grey matter volume were obtained from 52 individuals with a chronic schizophrenia-spectrum disorder, 28 youth with recent-onset psychosis, 52 older healthy controls, and 28 younger healthy controls. Both chronic and recent-onset patients had impaired visuospatial associative memory performance, however, only chronic patients showed hippocampal subfield volume loss. Both chronic and recent-onset patients demonstrated relationships between visuospatial associative memory performance and hippocampal subfield volumes in the CA4/dentate gyrus and the stratum that were not observed in older healthy controls. There were no group by volume interactions when chronic and recent-onset patients were compared. The current study extends the findings of previous studies by identifying particular hippocampal subfields, including the hippocampal stratum layers and the dentate gyrus, that appear to be related to visuospatial associative memory ability in individuals with both chronic and first-episode psychosis.

Sections du résumé

BACKGROUND
While previous studies have identified relationships between hippocampal volumes and memory performance in schizophrenia, these relationships are not apparent in healthy individuals. Further, few studies have examined the role of hippocampal subfields in illness-related memory deficits, and no study has examined potential differences across varying illness stages. The current study aimed to investigate whether individuals with early and established psychosis exhibited differential relationships between visuospatial associative memory and hippocampal subfield volumes.
METHODS
Measurements of visuospatial associative memory performance and grey matter volume were obtained from 52 individuals with a chronic schizophrenia-spectrum disorder, 28 youth with recent-onset psychosis, 52 older healthy controls, and 28 younger healthy controls.
RESULTS
Both chronic and recent-onset patients had impaired visuospatial associative memory performance, however, only chronic patients showed hippocampal subfield volume loss. Both chronic and recent-onset patients demonstrated relationships between visuospatial associative memory performance and hippocampal subfield volumes in the CA4/dentate gyrus and the stratum that were not observed in older healthy controls. There were no group by volume interactions when chronic and recent-onset patients were compared.
CONCLUSIONS
The current study extends the findings of previous studies by identifying particular hippocampal subfields, including the hippocampal stratum layers and the dentate gyrus, that appear to be related to visuospatial associative memory ability in individuals with both chronic and first-episode psychosis.

Identifiants

pubmed: 30511607
pii: S0033291718003458
doi: 10.1017/S0033291718003458
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2452-2462

Auteurs

Cassandra M J Wannan (CMJ)

Department of Psychiatry, Melbourne Neuropsychiatry Centre, The University of Melbourne and Melbourne Health, Carlton South, Victoria, Australia.
Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Victoria, Australia.
The Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
The Cooperative Research Centre for Mental Health, Melbourne, Australia.
North Western Mental Health, Melbourne Health, Parkville, VIC, Australia.

Vanessa L Cropley (VL)

Department of Psychiatry, Melbourne Neuropsychiatry Centre, The University of Melbourne and Melbourne Health, Carlton South, Victoria, Australia.
Centre for Mental Health, Faculty of Health, Arts and Design, School of Health Sciences, Swinburne University, Melbourne, Australia.

M Mallar Chakravarty (MM)

Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, Canada.
Departments of Psychiatry and Biological and Biomedical Engineering, McGill University, Montreal, Canada.

Tamsyn E Van Rheenen (TE)

Department of Psychiatry, Melbourne Neuropsychiatry Centre, The University of Melbourne and Melbourne Health, Carlton South, Victoria, Australia.
Centre for Mental Health, Faculty of Health, Arts and Design, School of Health Sciences, Swinburne University, Melbourne, Australia.

Sam Mancuso (S)

Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.

Chad Bousman (C)

Departments of Medical Genetics, Psychiatry, and Physiology & Pharmacology, University of Calgary, AB, Canada.
Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, Calgary, AB, Canada.

Ian Everall (I)

The Cooperative Research Centre for Mental Health, Melbourne, Australia.
Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.
Department of Electrical and Electronic Engineering, Centre for Neural Engineering, University of Melbourne, South Carlton, Victoria, Australia.
Institute of Psychiatry, Psychology, and Neuroscience, King's College London, UK.
Florey Institute for Neuroscience & Mental Health, Parkville, VIC, Australia.

Patrick D McGorry (PD)

Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Victoria, Australia.

Christos Pantelis (C)

Department of Psychiatry, Melbourne Neuropsychiatry Centre, The University of Melbourne and Melbourne Health, Carlton South, Victoria, Australia.
The Cooperative Research Centre for Mental Health, Melbourne, Australia.
North Western Mental Health, Melbourne Health, Parkville, VIC, Australia.
Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.
Department of Electrical and Electronic Engineering, Centre for Neural Engineering, University of Melbourne, South Carlton, Victoria, Australia.
Florey Institute for Neuroscience & Mental Health, Parkville, VIC, Australia.

Cali F Bartholomeusz (CF)

Department of Psychiatry, Melbourne Neuropsychiatry Centre, The University of Melbourne and Melbourne Health, Carlton South, Victoria, Australia.
Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Victoria, Australia.
The Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH